26.

Matsui H, Ito S, Matsui H, Ito J, Gabdulkhaev R, Hirose M, Yamanaka T, Koyama A, Kato T, Tanaka M, Uemura N, Matsui N, Hirokawa S, Yoshihama M, Shimazawa A, Kubo S, Iwasaki K, Hasegawa M, Takahashi R, Hirai K, Kakita A, Onodera O (2023) Phosphorylation of a-synuclein at T64 results in distinct oligomers and exerts toxicity in models of Parkinson’s disease. Prog Natl Acad Sci USA  120 (23): e2214652120

25.

Miyahara K, Hino M, Shishido R, Nagaoka A, Hayashi H, Kakita A, Yabe H, Yomita H, Kunii Y (2023) Identification of schizophrenia symptom-related gene modules by postmortem brain transcriptome analysis. Transl Psychiatry 13 (1): 144

24.

柿田明美．リピート病総論．5. リピート伸長病．IV. 変性疾患．非腫瘍性疾患病理アトラス 中枢神経．新井信隆（編）．文光堂．total. ###pages. in press

23.

Ogata A, Yamada T, Hattori S, Ikenuma H, Abe J, Tada M, Ichise M, Suzuki M, Ito K, Kato T, Amaike K, Hirota T, Kakita A, Itami K, Kimura Y (2023) Development of a novel PET ligand, [¹¹C]GO289 targeting CK2 expressed in the brain. Bioorg Med Chem Lett 2 90: 129327

22.

Watanabe M, Nakamura K, Saito R, Takeuchi A, Takahashi T, Onodera O, Kitamoto T, Kakita A (2023) V180I genetic Creutzfeldt-Jakob disease: an autopsied patient presenting severe degeneration of the inferior olivary nucleus with M2T prion strain. Neuropathology, in press

21.

他田真理. 第19章 神経. 20. Alzheimer病 (老人斑、神経原線維変化). 22. 脳アミロイド血管症. 23. 多発性硬化症. 病理診断クイックリファレンス2023.「病理と臨床」編集委員会. 文光堂, 東京. pp. 335, 337, 338. total 364 pages. 2023年.

20.

Takahashi H, Natsumeda M, On J, Watanabe J, Tada M, Shimizu H, Tsukamoto Y, Okada M, Oishi M, Takizawa J, Hayashi Y, Masaki Y, Kakita A, Fujii Y (2023) Administration of glucocorticoids prior to liquid biopsy dramatically reduces the detection rate of MYD88 L265P mutation in cerebrospinal fluid of primary CNS lymphoma patients. Leuk Lymphoma, in press

19.

Takahashi K, Kanekiyo K, Sakuda K, Muto Y, Iguchi M, Matsuda N, Hashimoto Y, Kanai K, Ogawa H, Hirase H, Kakita A, Bizen N, Takebayashi H, Kawaguchi Y, Uzuki M, Kitazume S (2023) Brain-specific glycosylation of PTPRZ marks a demyelination-associated astrocyte subtype. J Neurochem, in press

18.

Tsukamoto Y, Natsumeda M, Takahashi H, On J, Seto D, Saitou T, Shibuya K, Ogura R, Ito J, Oishi M, Shimizu H, Okamoto K, Kakita A, Fujii Y (2023 ) Diffusely infiltrating gliomas with poor prognosis, TERT promotor mutations and histological anaplastic pleomorphic xanthoastrocytoma-like appearance classify as mesenchymal subtype of glioblastoma, IDH-wildtype by methylation analysis Neurosurgery Practice 4 (2): e00040

17．

Tojima M, Kobayashi K, Hitomi T, Ishibashi H, Yoshii D, Sainouchi M, Ayaki T, Shimotake A, Usami K, Maki T, Kakita A, Takahashi R, Ikeda A (2023) A super elderly autopsy case of benign adult familiar myoclonus epilepsy with a heterozygous mutation. Epileptic Disord, in press

16．

宮下哲典, 原 範和, 春⽇健作, 菊地正隆, 尾崎浩⼀, 新飯⽥俊平, 他⽥真理, 柿⽥明美, 池内 健.APOE の遺伝型とレアミスセンスバリアント：臨床応⽤への可能性.Dementia Jpn, in press.

15.

柿田明美．てんかん原性脳病変の外科病理：皮質異形成と腫瘍．特集：All About Epilepsy（編　三村　將）．Brain Nerve 2023; 75 (4): 335-339. 医学書院，東京.

14.

柿田明美、川合謙介．第５章 皮質形成異常によるてんかん．1. 総論．てんかん症候群の診断と治療の手引き．日本てんかん学会（編集）メディカルレビュー社，東京．Pp. ###-###. Total ### pages. 2023年．in press

13.

松尾 健、柿田明美．第９章 腫瘍／腫瘍性病変によるてんかん．1. 総論．てんかん症候群の診断と治療の手引き．日本てんかん学会（編集）メディカルレビュー社，東京．Pp. ###-###. Total ### pages. 2023年．in press

12.

井内俊彦、柿田明美．Melanocytic lesions．脳腫瘍臨床病理カラーアトラス 第５版．日本脳腫瘍病理学会（編集）．医学書院，東京．pp. ###-###. total ### pages．2023年．in press

11.

西岡 宏、柿田明美．Nasal glial heterotopia．脳腫瘍臨床病理カラーアトラス 第５版．日本脳腫瘍病理学会（編集）．医学書院，東京．pp. ###-###. total ### pages．2023年．in press

10.

柿田明美． 脳神経系．10. 臓器別疾患．歯学生のための基礎病理学．田沼順一、豊澤 悟、岡田康男、松坂賢一（編集）、医歯薬出版　東京．2023年、in press

9.

Nakata S, Murai J, Okada M, Takahashi H, Findlay TH, Malebranche K, Parthasarathy A, Miyashita S, Gabdulkhaev R, Benkimoun I, Druillennec S, Chabi S, Hawkins E, Miyahara H, Tateishi K, Yamashita S, Yamada S, Saito T, On J, Watanabe J, Tsukamoto Y, Yoshimura J, Oishi M, Nakano T, Imamura M, Imai C, Yamamoto T, Takeshima H, Sasaki AT, Rodriguez FJ, Nobusawa S, Varlet P, Pouponnot C, Osuka S, Pommier Y, Kakita A, Fujii Y, Raabe EH, Eberhart CG, Natsumeda M (2023) Epigenetic upregulation of Schlafen11 renders WNT- and SHH-activated medulloblastomas sensitive to cisplatin. Neuro Oncol  25 (5): 899-912

8.

Ando K, Natsumeda M, Kawamura M, Shirakawa K, Okada M, Tsukamoto Y, Eda T, Watanabe J, Saito S, Takahashi H, Kakita A, Oishi M, Fujii Y (2023) Elevated ratio of type C lectin-like receptor 2 level and platelet count (C2PAC) aids in the diagnosis of post-operative venous thromboembolism in IDH-wildtype gliomas. Thrombosis Res 223: 36-43

7.

Zhou Y, Tada M, Cai Z, Andhey PS, Swain A, Miller KR, Gilfillan S, Artyomov MN, Takao M, Kakita A, Colonna M (2023) Human early-onset dementia caused by DAP12 deficiency reveals a unique signature of dysregulated microglia. Nat Immunol 24 (3): 545-557

6.

Fujita A, Kato M, Sugano H, Iimura Y, Suzuki H, Tohyama J, Fukuda M, Ito Y, Baba S, Okanishi T, Enoki H, Fujimoto A, Yamamoto A, Kawamura K, Kato S, Honda R, Ono T, Shiraishi H, Egawa K, Shirai K, Yamamoto S, Hayakawa I, Saida K, Tsuchida N, Uchiyama Y, Hamanaka K, Miyatake S, Mizuguchi T, Nakashima M, Saitsu H, Miyake N, Kakita A, Matsumoto N (2023) An integrated genetic analysis of epileptogenic brain malformed lesions. Acta Neuropathol Commun 11 (1): 33

5.

小柳清光、橋本智代、和田 学、山崎峰雄、中原亜紗、柿田明美 (2023)．グアム島と西ニューギニアのALS（筋萎縮性側索硬化症）とは何であり、医学はそれらから何を学んだのか．Clin Neurosci  41 (3): 325-329

4.

Saito Y, Sugai K, Atobe M, Sato N, Kakita A, Saito Y, Ohtsuki T, Iwasaki M, Sasaki M (2023).Periodic cycles of seizure clustering and suppression in children strongly suggest focal cortical dysplasia. Dev Med Child Neurol  65 (3): 431-436

3.

Saito R, Hara N, Tada M, Wakabayashi M, Miyashita A, Onodera O, Ikeuchi T, Kakita A (2023). SYNE1-ataxia: clinicopathologic features of an autopsied patient with novel compound heterozygous mutations. J Neuropathol Exp Neurol  82 (3): 267-271

2.

Nomura K, Suzuki H, Iimura Y, Mitsuhashi T, Ueda T, Nishioka K, Fusegi K, Nakajima M, Kakita A, Sugano H (2023). Epilepsy surgery without lipoma removal for temporal lobe epilepsy associated with Sylvian fissure lipoma: a case report.Acta Neurochir (Wien) 165 (1): 265-269

1.

Sakai K, Noguchi-Shinohara M, Tanaka H, Ikeda T, Hamaguchi T, Kakita A, Yamada M, Ono K (2023). Cerebrospinal fluid biomarkers and Amyloid-b elimination from the brain in cerebral amyloid angiopathy-related inflammation. J Alzheimer Dis  91 (3): 1173-1183